RUNX2 level has been reported to be upregulated in GBM, and the cross-talk between Cyclic 3′,5′-adenosinemonophosphate/protein kinase A (c-AMP/PKA) signaling and RUNX2 can promote the malignant phenotype of GBM cells [27]. Here, RUNX2 is linked to glioblastoma.